Core Laboratories (CLB) Tops Q1 EPS by 3c; Issues Solid Outlook
Tweet
Share
E-mailGet Alerts CLB Hot Sheet
Price: $10.94 --0%
EPS Growth %: +45.5%
Financial Fact:
Net Income (Loss) Attributable to Non-controlling Interest: 108K
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: +45.5%
Financial Fact:
Net Income (Loss) Attributable to Non-controlling Interest: 108K
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Core Laboratories (NYSE: CLB) reported Q1 EPS of $0.42, $0.03 better than the analyst estimate of $0.39. Revenue for the quarter came in at $158 million versus the consensus estimate of $150.57 million.
GUIDANCE:
Core Laboratories sees Q2 2017 EPS of $0.48-$0.52, versus the consensus of $0.48.
For earnings history and earnings-related data on Core Laboratories (CLB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- AutoZone (AZO) Tops Q4 EPS by $1.76, Misses on Revenue
- BTIG Assumes MGIC Investment (MTG) at Neutral
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
